These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6715565)

  • 21. Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.
    Hawkey CJ; Hawthorne AB; Hudson N; Cole AT; Mahida YR; Daneshmend TK
    Clin Sci (Lond); 1991 Oct; 81(4):565-73. PubMed ID: 1657506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
    Moberly JB; Harris SI; Riff DS; Dale JC; Breese T; McLaughlin P; Lawson J; Wan Y; Xu J; Truitt KE
    Dig Dis Sci; 2007 Feb; 52(2):442-50. PubMed ID: 17216336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renal excretion of prostaglandins and changes in plasma renin during treatment with either sulindac or naproxen in patients with rheumatoid arthritis and thiazide treated heart failure.
    Svendsen UG; Gerstoft J; Hansen TM; Christensen P; Lorenzen I
    J Rheumatol; 1984 Dec; 11(6):779-82. PubMed ID: 6394759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa.
    Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF
    Am J Gastroenterol; 1981 Jan; 75(1):17-21. PubMed ID: 7234826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
    Graham DY; Malaty HM; Goodgame R
    Am J Gastroenterol; 1997 Aug; 92(8):1322-5. PubMed ID: 9260798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ibuprofen, tolmetin and placebo on the gastric mucosa of aspirin-sensitive volunteers.
    Lanza FL; Nelson RS; Royer GL
    Am J Gastroenterol; 1979 Nov; 72(5):528-34. PubMed ID: 532796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological study of the effects of three anti-inflammatory preparations on the gastric mucosa.
    McIntyre RL; Irani MS; Piris J
    J Clin Pathol; 1981 Aug; 34(8):836-42. PubMed ID: 7276205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.
    Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C
    Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal blood loss after a new anti-inflammatory drug, sulindac.
    Cohen A
    Clin Pharmacol Ther; 1976 Aug; 20(2):238-40. PubMed ID: 1084825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naproxen and sulindac in the treatment of osteoarthritis of the hip and knee.
    Liyanage SP; Macauley DI; English JR
    Rheumatol Rehabil; 1981 Aug; 20(3):184-7. PubMed ID: 7025178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection by misoprostol against naproxen-induced gastric mucosal damage.
    Aadland E; Fausa O; Vatn M; Cohen H; Quinlan D
    Am J Med; 1987 Jul; 83(1A):37-40. PubMed ID: 3113244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-centre study of sulindac versus naproxen in the treatment of elderly osteoarthritic patients.
    Janke PG; Diggins JB; Currie WJ; Dasgupta PK; Glick EN; Sheikh NA; Shujja-Ud-Din
    Pharmatherapeutica; 1984; 3(10):663-7. PubMed ID: 6379679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing.
    Dikman A; Sanyal S; VON Althann C; Whitson M; Desai J; Bodian C; Brooks A; Bamji N; Cohen L; Miller K; Aisenberg J
    Aliment Pharmacol Ther; 2009 Apr; 29(7):781-91. PubMed ID: 19183162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic beta-carotene supplementation does not alter the gastric mucosal response to acute aspirin ingestion.
    Moses FM; Kikendall JW; Bowen P; Young TR
    J Clin Gastroenterol; 1990 Jun; 12(3):267-70. PubMed ID: 2362094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single blind randomized endoscopic study comparing the effects of diflunisal and naproxen in patients with osteoarthritis.
    Garber EK; Guth PH; Silpa ML; Stolz A
    J Rheumatol; 1986 Aug; 13(4):784-8. PubMed ID: 3534261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract.
    Marshall JK; Rainsford KD; James C; Hunt RH
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1451-7. PubMed ID: 11069316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin and the stomach.
    Graham DY; Smith JL
    Ann Intern Med; 1986 Mar; 104(3):390-8. PubMed ID: 3511824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.